Juvenile arthritis is treated with medicines that control inflammation, reduce joint pain, and protect growing joints from damage. Treatment may also include physical therapy, regular eye examinations, healthy daily habits, and ongoing medical monitoring. The exact approach depends on the child's type of arthritis, affected joints, age, and response to treatment.
Juvenile idiopathic arthritis (JIA) is the most common form of arthritis in children. Although it is a long-term condition, early and appropriate treatment can help many children achieve remission, maintain joint movement, and participate in everyday activities.
Step 1: Work with a pediatric rheumatologist
The first step in treating juvenile arthritis is getting care from a pediatric rheumatologist. This is a doctor who specializes in arthritis and other conditions affecting children's joints, muscles, bones, and immune systems.
Before recommending treatment, the specialist considers several factors, including:
- Type of juvenile arthritis: Different forms of JIA may respond to different medicines.
- Number of affected joints: Arthritis affecting a few joints may require a different approach from arthritis involving many joints.
- Inflammation levels: The doctor evaluates joint swelling, stiffness, examination findings, and relevant blood test results.
- Other symptoms: Fever, skin changes, eye inflammation, and other features may influence treatment choices.
- Age and development: Treatment must account for the child's growth, physical development, and daily activities.
- Previous treatment response: The specialist considers whether earlier medicines controlled inflammation and whether side effects occurred.
According to the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), treatment aims to control inflammation, protect joints and other organs, preserve movement, and support normal physical and social development.
Step 2: Start the appropriate medication
Medication is the foundation of juvenile arthritis treatment. The goal is not simply to reduce pain but also to control the inflammation responsible for joint problems.
Depending on the child's condition, a pediatric rheumatologist may recommend one or more of the following medication groups.
1. Nonsteroidal anti-inflammatory drugs (NSAIDs)
NSAIDs help reduce joint pain, swelling, and stiffness. They are commonly used for symptom relief, particularly in children with limited joint involvement or while other treatments take effect.
Examples include:
- Ibuprofen.
- Naproxen.
These medicines reduce inflammation and can make everyday activities more comfortable. However, they may not adequately control the underlying disease in children with more active or widespread arthritis.
Possible side effects include stomach discomfort, nausea, and problems involving the kidneys. The doctor determines the appropriate medicine and dose based on the child's age, weight, medical history, and other medications.
2. Disease-modifying antirheumatic drugs (DMARDs)
When inflammation continues despite initial treatment, or when the pattern of arthritis requires stronger disease control, the doctor may prescribe a disease-modifying antirheumatic drug (DMARD).
These medicines work on the immune system to reduce the inflammation that contributes to joint damage.
Methotrexate is one of the most commonly used conventional DMARDs for juvenile arthritis. It may be prescribed as a tablet or an injection under the skin.
Methotrexate can take several weeks to show its full effect. Doctors may prescribe folic acid alongside it to help reduce certain side effects.
Possible side effects include nausea, mouth sores, changes in blood cell counts, and liver-related problems. Regular blood tests help monitor safety during treatment.
Methotrexate is generally taken once weekly, not daily. Families should follow the prescribed schedule carefully because taking it incorrectly can cause serious harm.
3. Biologic medicines
Biologic medicines are targeted treatments that block specific immune system signals involved in inflammation.
A pediatric rheumatologist may recommend a biologic when conventional DMARDs do not provide enough disease control, or when the child's arthritis pattern and disease activity make targeted treatment appropriate earlier.
Examples include:
- Adalimumab: Blocks tumor necrosis factor (TNF), a protein involved in inflammation.
- Etanercept: Reduces the activity of TNF.
- Tocilizumab: Blocks interleukin-6 (IL-6), an inflammatory signal.
- Canakinumab: Blocks interleukin-1 (IL-1).
- Abatacept: Modifies certain immune cell activities involved in inflammation.
These medicines are usually given by injection or intravenous infusion, depending on the specific medication.
Biologics can help control inflammation when other treatments are insufficient. However, they may increase the risk of infections because they affect immune system activity. Doctors may recommend infection screening and vaccination planning before starting treatment.
4. Corticosteroids
Corticosteroids are powerful medicines that reduce inflammation quickly. They may be used in selected situations, including significant joint inflammation or certain systemic forms of juvenile arthritis.
There are two common approaches:
- Joint injections: A corticosteroid is injected directly into an affected joint to reduce local inflammation.
- Systemic corticosteroids: These medicines are taken by mouth or given through a vein when more widespread inflammation requires treatment.
Doctors generally try to limit long-term systemic corticosteroid use in children because prolonged exposure may affect growth, bone health, weight, and infection risk.
The Arthritis Foundation describes these medication options and explains how doctors select treatments according to the type of juvenile arthritis and the child's response.
Step 3: Adjust treatment according to the type of juvenile arthritis
Not every child with juvenile arthritis needs the same combination of medicines. Treatment decisions depend partly on the particular JIA category and the body systems involved.
Oligoarticular juvenile arthritis
Oligoarticular JIA affects a small number of joints. Treatment may begin with an NSAID and, when appropriate, corticosteroid injections into affected joints.
If inflammation continues, a DMARD such as methotrexate may be considered. Some children need additional targeted treatment depending on their response.
Polyarticular juvenile arthritis
Polyarticular JIA affects five or more joints. Because multiple joints are involved, treatment often requires a disease-modifying medicine rather than relying on pain-relieving medication alone.
Methotrexate is commonly considered as an initial DMARD. A biologic may be added or selected when disease activity remains high or the child's clinical circumstances support earlier targeted treatment.
Systemic juvenile arthritis
Systemic JIA can affect joints and other parts of the body. Children may experience fever, skin rashes, and inflammation involving organs in addition to joint symptoms.
Treatment may include biologic medicines that block IL-1 or IL-6. These targeted treatments are important options for controlling systemic inflammation. The choice depends on the child's overall condition and whether there are complications such as macrophage activation syndrome (MAS).
Enthesitis-related arthritis
Enthesitis-related arthritis affects areas where tendons or ligaments attach to bones. It may also involve the hips, lower back, or other joints.
NSAIDs may help with symptoms. If inflammation persists, doctors may consider DMARDs or biologic treatments, depending on the joints and structures involved.
Juvenile arthritis affecting the jaw
Temporomandibular joint (TMJ) arthritis affects the joint connecting the jaw to the skull. It can interfere with chewing, speaking, and normal jaw movement.
Treatment may involve systemic medicines, joint-specific treatment, and assessment by specialists familiar with jaw development and function.
Step 4: Include physical therapy and occupational therapy
Medicines control inflammation, but children may also need therapy to maintain movement, muscle strength, and independence.
Physical therapy and occupational therapy address different aspects of daily functioning.
How physical therapy helps
A physical therapist develops an exercise plan based on the child's affected joints, movement limitations, and physical abilities.
Physical therapy may help:
- Maintain flexibility and joint movement.
- Strengthen muscles surrounding affected joints.
- Improve balance, coordination, and endurance.
- Reduce movement difficulties associated with stiffness.
- Support a gradual return to age-appropriate physical activities.
How occupational therapy helps
Occupational therapists help children manage everyday activities with greater comfort and independence.
They may suggest practical changes such as:
- Using specially designed pencils or utensils when hand movement is difficult.
- Adjusting seating and desk arrangements at school.
- Using splints or other supportive devices when appropriate.
- Learning easier ways to dress, write, and complete daily tasks.
According to the American College of Rheumatology (ACR) treatment guideline, physical and occupational therapy are important parts of JIA management. These interventions can help maintain joint movement, improve strength, and support participation in daily activities.
Step 5: Protect eye health with regular examinations
Juvenile arthritis can sometimes cause uveitis, which is inflammation inside the eye. This complication may develop without obvious symptoms, so children cannot rely on pain, redness, or blurred vision to identify it.
Regular examinations by an ophthalmologist are an important part of long-term care.
The frequency of eye screening depends on factors such as:
- The type of juvenile arthritis.
- The child's age when arthritis began.
- The duration of the condition.
- Antinuclear antibody (ANA) test results.
- Previous eye inflammation.
An ophthalmologist may use a slit-lamp examination to look for inflammation inside the eye.
If uveitis is detected, treatment may include prescription eye drops, such as corticosteroids, or systemic medicines when necessary. The ophthalmologist and pediatric rheumatologist coordinate care to protect vision.
Eye screening should continue according to the specialist's schedule, even when joint symptoms are well controlled.
Step 6: Support treatment with healthy daily habits
Healthy lifestyle habits cannot replace medication, but they can support a child's general health, strength, and ability to remain active.
Encourage regular, joint-friendly exercise
Appropriate physical activity helps maintain flexibility, muscle strength, and fitness. Children should be encouraged to remain active within their physical abilities.
Activities that may be suitable include:
- Swimming or water-based exercise.
- Walking.
- Gentle stretching.
- Cycling, when comfortable.
- Age-appropriate strengthening exercises recommended by a therapist.
Exercise should be adjusted during periods of increased joint inflammation. Activities that cause significant joint pain or place excessive stress on affected joints may need modification.
Provide a balanced, age-appropriate diet
Children with juvenile arthritis need enough nutrients to support normal growth and development.
Include a variety of foods such as:
- Fruits and vegetables.
- Whole grains.
- Milk, yogurt, or other suitable calcium-rich foods.
- Protein sources such as eggs, fish, beans, lentils, and lean meat.
- Healthy fats from nuts, seeds, and suitable oils.
Children taking certain arthritis medicines may need additional nutritional attention, particularly when treatment affects appetite, bone health, or growth.
There is no established special diet that cures juvenile arthritis. Restrictive diets and herbal supplements should not replace prescribed treatment. Families should discuss significant dietary changes with the child's healthcare team.
Balance activity with adequate rest
Fatigue can make everyday activities more difficult for children with arthritis. Encourage a regular sleep schedule and allow breaks when the child feels tired or experiences increased discomfort.
Alternating activity with rest can help children maintain participation in school, play, and family activities without overworking painful joints.
Step 7: Attend regular follow-up appointments and monitoring tests
Juvenile arthritis treatment requires ongoing assessment. A medicine that initially works well may need adjustment if inflammation returns, symptoms continue, or side effects develop.
During follow-up appointments, the healthcare team may evaluate:
- Joint swelling, tenderness, and range of motion.
- Morning stiffness and changes in daily activity.
- Growth, weight, and physical development.
- Response to prescribed medicines.
- Possible medication side effects.
- Eye examination results and other complications.
Which blood tests may be needed?
Some arthritis medicines require regular blood testing to check for possible side effects and monitor treatment safety.
Depending on the medication, tests may include:
- Complete blood count (CBC): Checks blood cells, including red blood cells, white blood cells, and platelets.
- Liver function tests: Help identify possible liver-related effects of treatment.
- Kidney function tests: Assess kidney health during certain treatments.
- Inflammatory markers: Tests such as ESR and CRP may help assess inflammation and monitor disease activity in selected children.
The timing of these tests depends on the medicine being used and the child's medical circumstances. For example, methotrexate requires specific laboratory monitoring after treatment begins and at regular intervals thereafter.
Review vaccinations before and during treatment
Some medicines used for juvenile arthritis affect immune system activity and may change which vaccines are appropriate or when they should be given.
Parents should discuss the child's vaccination schedule with the rheumatologist. Live vaccines may require special consideration for children receiving certain immunosuppressive medicines. Families should not stop treatment or delay vaccination without medical guidance.
Step 8: Adjust treatment if the condition is not improving
Not every child responds to the first medicine prescribed. If joint inflammation continues, the pediatric rheumatologist may reassess the treatment plan.
Possible adjustments include:
- Changing the dose of an existing medicine.
- Switching to another DMARD.
- Adding a biologic medicine.
- Using a different biologic that targets another inflammatory pathway.
- Considering a corticosteroid injection for selected affected joints.
- Reassessing physical therapy and other supportive treatments.
The doctor may also review whether another condition, infection, medication side effect, or complication is contributing to the child's symptoms.
Treatment decisions should consider the child's overall disease activity, joint function, eye health, and quality of life rather than pain levels alone.
Step 9: Continue treatment even when symptoms improve
When a child's joints become less painful and swollen, it may seem that arthritis has disappeared. However, symptom improvement does not always mean that inflammation has completely stopped.
Doctors assess whether the child has achieved remission by considering clinical examinations and other relevant findings. Remission means that there is little or no active disease.
If the condition remains well controlled, the rheumatologist may discuss gradually reducing medication. The timing and method depend on the type of arthritis, treatment history, and risk of relapse.
Families should never reduce, skip, or stop prescribed arthritis medicines without discussing the change with the treating specialist.
When should parents contact the doctor during treatment?
Some situations require medical attention even when a child is already receiving arthritis treatment.
- New or worsening joint swelling, stiffness, or difficulty walking.
- Persistent fever or a sudden change in the child's general health.
- Unusual bruising, bleeding, or other possible medication side effects.
- Repeated infections while taking immune-suppressing medicines.
- Eye pain, redness, light sensitivity, or changes in vision.
- New difficulty with everyday activities, school attendance, or physical movement.
A child receiving immune-suppressing treatment who develops a fever or appears unwell should receive prompt medical advice because infections may need special attention. A painful red eye or sudden change in vision also requires urgent assessment.
What is the long-term outlook for children with juvenile arthritis?
Many children with juvenile arthritis can lead active lives with appropriate treatment and regular monitoring. Advances in disease-modifying and biologic medicines have improved the ability to control inflammation and protect joint function.
Some children achieve remission and may eventually reduce or stop medication under medical supervision. Others experience periods of improvement followed by renewed inflammation and may need longer-term treatment.
The outlook depends on the type of arthritis, the joints and other organs involved, treatment response, and the presence of complications. Early disease control, regular eye screening, and coordinated care can help protect a child's health and development.
Parents can also support their children by maintaining communication with teachers, encouraging appropriate activities, and addressing emotional difficulties associated with living with a long-term condition. The goal is to help children participate in normal childhood experiences while keeping arthritis under control.